Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Radiation Biology
•
General Radiation Oncology
Do patients with homocystinuria have an increase risk of radiation toxicity?
Would one expect a higher risk of rad effects?
Related Questions
What is your preferred fractionation scheme for spine SBRT for radioresistant histologies?
What is your approach to management of radiation-induced bullous pemphigoid?
How do you manage intradural - extramedullary metastases of the spinal cord from non-CNS malignancies?
Would you re-irradiate a spleen with increasing splenomegaly for a patient with myelofibrosis?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
Do you routinely offer spine SBRT for vertebral metastases regardless of overall patient disease burden or response?
Would you hold CGRP (calcitonin gene-related peptide) monoclonal antibodies such as Eptinezumab-jjmr (Vyepti) before, during, or after lung SBRT?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
Can patients receive adjuvant radiation therapy after keloid excision without primary closure, or would radiation impede healing by secondary intention?
